Abstract | OBJECTIVE: DESIGN: Guinea pigs were randomly assigned to three groups receiving cochlear implantation trauma by cochleostomy. In one group, the site was sealed by bone cement with no further treatment. A second group was additionally implanted with an osmotic minipump delivering artificial perilymph into the scala tympani for seven days. In the third group, etanercept 1 mg/ml was added to artificial perilymph. Hearing was assessed by auditory brainstem responses at 2, 4, 6, and 8 kHz prior to and after surgery and on days 3, 5, 7, 14, 28. STUDY SAMPLE: Fifteen healthy guinea pigs. RESULTS: The trauma led to threshold shifts from 50.3 dB ± 16.3 dB to 68.0 dB ± 19.3 dB. Hearing thresholds were significantly lower in etanercept-treated animals compared to controls on day 28 at 8 kHz and from day 3 onwards at 4 and 2 kHz (p < 0.01; two-way RM ANOVA / Bonferroni t-test). CONCLUSION:
|
Authors | Friedrich Ihler, Sabrina Pelz, Melanie Coors, Christoph Matthias, Martin Canis |
Journal | International journal of audiology
(Int J Audiol)
Vol. 53
Issue 11
Pg. 810-6
(Nov 2014)
ISSN: 1708-8186 [Electronic] England |
PMID | 25311100
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Anti-Inflammatory Agents, Non-Steroidal
- Immunoglobulin G
- Receptors, Tumor Necrosis Factor
- Tumor Necrosis Factor-alpha
- Etanercept
|
Topics |
- Animals
- Anti-Inflammatory Agents, Non-Steroidal
(therapeutic use)
- Auditory Threshold
(drug effects)
- Cochlear Implantation
(adverse effects)
- Cochlear Implants
- Etanercept
- Evoked Potentials, Auditory, Brain Stem
(drug effects)
- Guinea Pigs
- Hearing Loss
(etiology, prevention & control)
- Immunoglobulin G
(therapeutic use)
- Infusion Pumps
- Receptors, Tumor Necrosis Factor
(therapeutic use)
- Scala Tympani
(surgery)
- Tumor Necrosis Factor-alpha
(antagonists & inhibitors)
|